The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study

Introduction: Traumatic brain injury (TBI) is one of the most common causes of death and an important burden to the worldwide healthcare system and society. There is a lack of guidelines for types of monitoring or neuroprotective therapy. The aim of this pilot study was to assess its feasibility and...

Full description

Bibliographic Details
Main Authors: Konrad Jarosz, Klaudyna Kojder, Karolina Skonieczna-Żydecka, Agata Andrzejewska, Joanna Sołek-Pastuszka, Anna Jurczak
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/13/2/353
_version_ 1797339707625963520
author Konrad Jarosz
Klaudyna Kojder
Karolina Skonieczna-Żydecka
Agata Andrzejewska
Joanna Sołek-Pastuszka
Anna Jurczak
author_facet Konrad Jarosz
Klaudyna Kojder
Karolina Skonieczna-Żydecka
Agata Andrzejewska
Joanna Sołek-Pastuszka
Anna Jurczak
author_sort Konrad Jarosz
collection DOAJ
description Introduction: Traumatic brain injury (TBI) is one of the most common causes of death and an important burden to the worldwide healthcare system and society. There is a lack of guidelines for types of monitoring or neuroprotective therapy. The aim of this pilot study was to assess its feasibility and, furthermore, to evaluate the impact of Cerebrolysin on the following clinical outcomes: length of stay, Glasgow Outcome Scale (GOS) and mortality. Methods: A cohort of 56 patients was included in this non-randomised, real-time, pre–post-interventional study. The patients were assessed with the Glasgow Coma Scale (GCS) and divided into two groups: severe (GCS < 8) and non-severe (GCS > 8). After the radiological examination (CT scan), the patients were qualified for an immediate neurosurgical procedure if needed. The patients were admitted to the intensive care unit, where a standardised protocol for TBI treatment was implemented. Additional neuromonitoring was applied. Results: There were 56 patients (19 females; 33.9%), of which 41 were considered severe cases; the patients were allocated to the Cerebrolysin (<i>n</i> = 25) or control groups (<i>n</i> = 31). In a generalised linear model (GLM) approach, the use of Cerebrolysin was associated with a decrease in the probability of death in non-severe patients (by 0.333 (standard error (SE) = 0.157, <i>p</i> = 0.034)) but not in severe patients (estimate (Est.) = −0.115, SE = 0.127, <i>p</i> = 0.364). Patients who received Cerebrolysin and who were neuromonitored had favourable outcomes and better survival rates. Conclusions: A multimodal treatment approach with monitoring and Cerebrolysin may have a beneficial effect on patients with less severe TBIs; however, the present study has multiple limitations, and further research is needed.
first_indexed 2024-03-08T09:52:16Z
format Article
id doaj.art-c507842c5fd24042937793a1cbfe1f67
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-08T09:52:16Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-c507842c5fd24042937793a1cbfe1f672024-01-29T14:01:03ZengMDPI AGJournal of Clinical Medicine2077-03832024-01-0113235310.3390/jcm13020353The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot StudyKonrad Jarosz0Klaudyna Kojder1Karolina Skonieczna-Żydecka2Agata Andrzejewska3Joanna Sołek-Pastuszka4Anna Jurczak5Anesthesiology and Intensive Care, University Hospital no. 1 Unii Lubelskiej, 71-252 Szczecin, PolandAnesthesiology and Intensive Care, University Hospital no. 1 Unii Lubelskiej, 71-252 Szczecin, PolandDepartment of Biochemical Sciences, Pomeranian Medical University, 71-460 Szczecin, PolandAnesthesiology and Intensive Care, University Hospital no. 1 Unii Lubelskiej, 71-252 Szczecin, PolandAnesthesiology and Intensive Care, University Hospital no. 1 Unii Lubelskiej, 71-252 Szczecin, PolandDepartment of Specialist Nursery, Pomeranian Medical University, Zolnierska 48, 71-210 Szczecin, PolandIntroduction: Traumatic brain injury (TBI) is one of the most common causes of death and an important burden to the worldwide healthcare system and society. There is a lack of guidelines for types of monitoring or neuroprotective therapy. The aim of this pilot study was to assess its feasibility and, furthermore, to evaluate the impact of Cerebrolysin on the following clinical outcomes: length of stay, Glasgow Outcome Scale (GOS) and mortality. Methods: A cohort of 56 patients was included in this non-randomised, real-time, pre–post-interventional study. The patients were assessed with the Glasgow Coma Scale (GCS) and divided into two groups: severe (GCS < 8) and non-severe (GCS > 8). After the radiological examination (CT scan), the patients were qualified for an immediate neurosurgical procedure if needed. The patients were admitted to the intensive care unit, where a standardised protocol for TBI treatment was implemented. Additional neuromonitoring was applied. Results: There were 56 patients (19 females; 33.9%), of which 41 were considered severe cases; the patients were allocated to the Cerebrolysin (<i>n</i> = 25) or control groups (<i>n</i> = 31). In a generalised linear model (GLM) approach, the use of Cerebrolysin was associated with a decrease in the probability of death in non-severe patients (by 0.333 (standard error (SE) = 0.157, <i>p</i> = 0.034)) but not in severe patients (estimate (Est.) = −0.115, SE = 0.127, <i>p</i> = 0.364). Patients who received Cerebrolysin and who were neuromonitored had favourable outcomes and better survival rates. Conclusions: A multimodal treatment approach with monitoring and Cerebrolysin may have a beneficial effect on patients with less severe TBIs; however, the present study has multiple limitations, and further research is needed.https://www.mdpi.com/2077-0383/13/2/353traumatic brain injury (TBI)CerebrolysinAmantadineneuromonitoringnear-infrared spectroscopy (NIRS)optic nerve sheath diameter (ONSD)
spellingShingle Konrad Jarosz
Klaudyna Kojder
Karolina Skonieczna-Żydecka
Agata Andrzejewska
Joanna Sołek-Pastuszka
Anna Jurczak
The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
Journal of Clinical Medicine
traumatic brain injury (TBI)
Cerebrolysin
Amantadine
neuromonitoring
near-infrared spectroscopy (NIRS)
optic nerve sheath diameter (ONSD)
title The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
title_full The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
title_fullStr The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
title_full_unstemmed The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
title_short The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
title_sort effects of neuromonitoring and cerebrolysin administration on outcomes in patients with traumatic brain injury an interventional pilot study
topic traumatic brain injury (TBI)
Cerebrolysin
Amantadine
neuromonitoring
near-infrared spectroscopy (NIRS)
optic nerve sheath diameter (ONSD)
url https://www.mdpi.com/2077-0383/13/2/353
work_keys_str_mv AT konradjarosz theeffectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT klaudynakojder theeffectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT karolinaskoniecznazydecka theeffectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT agataandrzejewska theeffectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT joannasołekpastuszka theeffectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT annajurczak theeffectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT konradjarosz effectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT klaudynakojder effectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT karolinaskoniecznazydecka effectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT agataandrzejewska effectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT joannasołekpastuszka effectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy
AT annajurczak effectsofneuromonitoringandcerebrolysinadministrationonoutcomesinpatientswithtraumaticbraininjuryaninterventionalpilotstudy